(Q54881683)

English

HCC2998

cell line

HCC-2998
HCC.2998
HCC 2998
Hamon Cancer Center 2998

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

13 July 2024

cancer cell line

1 reference

Cellosaurus release 49

13 July 2024

described by source

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

Cellosaurus release 49

13 July 2024

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

Cellosaurus release 49

13 July 2024

Recurrent KRAS codon 146 mutations in human colorectal cancer

1 reference

Cellosaurus release 49

13 July 2024

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

1 reference

Cellosaurus release 49

13 July 2024

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

1 reference

Cellosaurus release 49

13 July 2024

DNA fingerprinting of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

13 July 2024

Genomic and biological characterization of exon 4 KRAS mutations in human cancer

1 reference

Cellosaurus release 49

13 July 2024

5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency

1 reference

Cellosaurus release 49

13 July 2024

JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs

1 reference

Cellosaurus release 49

13 July 2024

Identification of cancer cell-line origins using fluorescence image-based phenomic screening

1 reference

Cellosaurus release 49

13 July 2024

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

1 reference

Cellosaurus release 49

13 July 2024

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

1 reference

Cellosaurus release 49

13 July 2024

Global proteome analysis of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

13 July 2024

The metabolic demands of cancer cells are coupled to their size and protein synthesis rates

1 reference

Cellosaurus release 49

13 July 2024

High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner

1 reference

Cellosaurus release 49

13 July 2024

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer

1 reference

Cellosaurus release 49

13 July 2024

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

1 reference

Cellosaurus release 49

13 July 2024

Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR

1 reference

Cellosaurus release 49

13 July 2024

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 49

13 July 2024

A map of mobile DNA insertions in the NCI-60 human cancer cell panel.

1 reference

Cellosaurus release 49

13 July 2024

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 49

13 July 2024

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies

1 reference

Cellosaurus release 49

13 July 2024

Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells.

1 reference

Cellosaurus release 49

13 July 2024

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

Cellosaurus release 49

13 July 2024

HLA class I and II genotype of the NCI-60 cell lines

1 reference

Cellosaurus release 49

13 July 2024

p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target

1 reference

Cellosaurus release 49

13 July 2024

Signatures of mutation and selection in the cancer genome

1 reference

Cellosaurus release 49

13 July 2024

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 49

13 July 2024

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

1 reference

Cellosaurus release 49

13 July 2024

APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer.

1 reference

Cellosaurus release 49

13 July 2024

Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location

1 reference

Cellosaurus release 49

13 July 2024

Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.

1 reference

Cellosaurus release 49

13 July 2024

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

1 reference

Cellosaurus release 49

13 July 2024

established from medical condition

colon adenocarcinoma

1 reference

Cellosaurus release 49

13 July 2024

derived from organism type

unknown value

2 references

Cellosaurus release 44

10 January 2023

Cellosaurus release 49

13 July 2024

http://purl.obolibrary.org/obo/BTO_0003322

1 reference

Cellosaurus release 49

13 July 2024

http://purl.obolibrary.org/obo/EFO_0005370

1 reference

Cellosaurus release 49

13 July 2024

http://purl.obolibrary.org/obo/CLO_0009962

1 reference

Cellosaurus release 49

13 July 2024

Identifiers

Cell Line Ontology ID

1 reference

Cellosaurus release 49

13 July 2024

1 reference

Cellosaurus release 49

13 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54881683&oldid=2258279202"